| dc.creator |
Bağcı, Ali |
|
| dc.creator |
Aksoy, Fatih |
|
| dc.date |
2021-06-01T00:00:00Z |
|
| dc.date.accessioned |
2021-12-03T11:19:23Z |
|
| dc.date.available |
2021-12-03T11:19:23Z |
|
| dc.identifier |
2adf867d-310b-496f-8d46-abd6e13db95b |
|
| dc.identifier |
10.2217/bmm-2020-0838 |
|
| dc.identifier |
https://avesis.sdu.edu.tr/publication/details/2adf867d-310b-496f-8d46-abd6e13db95b/oai |
|
| dc.identifier.uri |
http://acikerisim.sdu.edu.tr/xmlui/handle/123456789/90589 |
|
| dc.description |
Aim: To investigate the predictive capacity of a systemic immune-inflammation index (SII) in detecting new onset atrial fibrillation (NOAF) following ST segment elevation myocardial infarction (STEMI). Patients & methods: A total of 402 STEMI patients were enrolled in the study. The patients were divided into two groups according to NOAF development. Results: A cut-off point of 1,228,000 for SII was identified with 60% sensitivity and 78.1% specificity to predict NOAF following STEMI. According to pairwise analysis of receiver operating characteristic curve analysis, the predictive power of SII in detecting NOAF following STEMI was similar to high-sensitive C-reactive protein, and better than neutrophil-to-lymphocyte ratio or platelet-to-lymphocyte ratio. Conclusion: SII can be used as one of the independent predictors of NOAF following STEMI. |
|
| dc.language |
eng |
|
| dc.rights |
info:eu-repo/semantics/closedAccess |
|
| dc.title |
Systemic immune-inflammation index predicts new onset atrial fibrillation after ST elevation myocardial infarction |
|
| dc.type |
info:eu-repo/semantics/article |
|